Cotovio, Gonçalo
Faro Viana, Francisco
Fox, Michael D.
Oliveira-Maia, Albino J. http://orcid.org/0000-0001-5071-3007
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (SFRH/BD/130210/2017, FCT-PTDC/MED-NEU/31331/2017, FCT-PTDC/MED-NEU/31331/2017, FCT-PTDC/MEC-PSQ/30302/2017-IC&DT-LISBOA-01-0145-FEDER)
Sidney R. Baer, Jr. Foundation
Nancy Lurie Marks Family Foundation
Mather's Foundation
Foundation for the National Institutes of Health (R01 AG060987, R01 MH113929, R01 MH115949)
Article History
Received: 17 November 2021
Accepted: 8 May 2022
First Online: 16 May 2022
Declarations
:
: AJO-M was national coordinator for Portugal of a non-interventional study (EDMS-ERI-143085581, 4.0) to characterize a Treatment-Resistant Depression Cohort in Europe, sponsored by Janssen-Cilag, Ltd (2019–2020), is recipient of a grant from Schuhfried GmBH for norming and validation of cognitive tests, and is national coordinator for Portugal of trials of psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways, Ltd (EudraCT number 2017–003288-36 and 2020–001348-25), and of esketamine for treatment-resistant depression, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019–002992-33). None of the aforementioned agencies had a role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, in the preparation, review, or approval of the manuscript, nor in the decision to submit the manuscript for publication. The remaining authors have declared that they have no potential conflicts of interest involving this work, including relevant financial activities outside the submitted work and any other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing what is written.
: Data collection in the clinical cohort was approved by the ethics committee at Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal, in accordance with the Declaration of Helsinki, that, considering the retrospective nature of the study, waived the need for written informed consent.